Fatal acute pancreatitis caused by valproic acid.

Am J Forensic Med Pathol

Office of the Chief Medical Examiner, Boston, Massachusetts, USA.

Published: March 1995

We describe a case of a 31-year-old woman with cerebral palsy who developed fatal acute hemorrhagic pancreatitis while being treated with valproic acid to control her seizure activity. Acute pancreatitis is usually due to alcohol ingestion or biliary tract disease, and unusual causes include trauma, metabolic diseases, or drugs. Valproic acid is considered a safe drug, although rare cases of severe toxicity such as hepatitis and acute pancreatitis, including two fatalities, have been reported. Our review of the literature revealed that most patients who developed acute pancreatitis had serum levels of the drug within the therapeutic range, and most of the cases occurred either secondary to a recent increase in the dose or to initiation of treatment. It also appeared that the fatalities occurred due to a delayed diagnosis of acute pancreatitis, either resulting from an unsuspected diagnosis or to the deteriorated mental status of the patients receiving the drug, which precluded their ability to elaborate symptomatology. We believe that early diagnosis and withdrawal of the drug are significant factors determining the course of valproic-acid-associated pancreatitis.

Download full-text PDF

Source
http://dx.doi.org/10.1097/00000433-199503000-00014DOI Listing

Publication Analysis

Top Keywords

acute pancreatitis
20
valproic acid
12
fatal acute
8
pancreatitis
7
acute
5
pancreatitis caused
4
caused valproic
4
acid describe
4
describe case
4
case 31-year-old
4

Similar Publications

Prognostic significance of albumin corrected anion gap in patients with acute pancreatitis: a novel perspective.

Sci Rep

January 2025

NHC Key Laboratory of Nuclear Technology Medical Transformation, School of Medicine, Mianyang Central Hospital, University of Electronic Science and Technology of China, Mianyang, 621000, China.

This study aims to explore the relationship between the albumin-corrected anion gap (ACAG) and short- and long-term all-cause mortality (ACM) in patients with acute pancreatitis (AP) managed in the intensive care unit (ICU). We conducted a retrospective analysis utilizing data extracted from the Medical Information Mart for Intensive Care-IV (MIMIC-IV) database. This study sought to investigate the correlation between ACAG and ACM among patients diagnosed with AP across various disease stages.

View Article and Find Full Text PDF

[Research advances on the genetic pathogenesis and gene therapy for pancreatitis].

Zhonghua Yi Xue Yi Chuan Xue Za Zhi

January 2025

Research Institute for Pancreatic Diseases of Shanghai, Department of Gastroenterology, Changhai Hospital, Naval Medical University, Shanghai 200433, China.

Pancreatitis is an inflammatory disease influenced by both environmental and genetic factors. It has a high prevalence and mortality rate worldwide, with no radical cure. Breakthroughs have been recently made in genetic research of pancreatitis.

View Article and Find Full Text PDF

Reducing the Risk of Pancreatitis by Inhibiting APOC3.

N Engl J Med

January 2025

From the Cardiovascular Division, Department of Medicine, and the Department of Genetics, Washington University School of Medicine, St. Louis.

View Article and Find Full Text PDF

Introduction: Endoscopic retrograde cholangiopancreatography (ERCP) is indicated for multiple pancreatic and biliary pathologies and carries a heightened risk profile compared with other endoscopic procedures. Considerable research has been directed towards discerning risk factors associated with complications such as post-ERCP pancreatitis and post-ERCP bleeding. Despite this, data on chronic liver disease (CLD) as a risk factor for complications is limited.

View Article and Find Full Text PDF

Pancreatic cancer (PC) manifests as a highly aggressive neoplastic growth, ranking as the fourth major contributor to cancer-related mortality in the United States. Despite sustained efforts, the incidence of PC is projected to rise, and the mortality rate has seen only a marginal reduction over time. A mere 15% of pancreatic cancer cases are deemed resectable upon presentation, explaining the notably low 5-year survival rate associated with this malignancy.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!